Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hamilton
Clinical trial register · Canada

Clinical Trials in Hamilton, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6567 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:20 UTC
6567
Studies in scope
all four open statuses
3485
Recruiting now
open to new participants
883
Lead sponsors
across recruiting studies
Top sites
Toronto 45 Montreal 27 London 22 Calgary 22 Québec 21

Trials with a site in Hamilton

20 of 6567 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
Eli Lilly and Company
Phase 3
1,000
Calgary, Hamilton, Kelowna, Lévis, Montreal, Ottawa, Québec, Richmond
2026-02-09
Recruiting
Eli Lilly and Company
Phase 3
1,980
Brampton, Courtice, Guelph, Hamilton, Québec, Sarnia, Stoney Creek, Trois-Rivières
2026-02-06
Active, closed
Eli Lilly and Company
Phase 3
600
Brampton, Courtice, Hamilton, Joliette, London, Québec, Sherbrooke, Toronto
2026-01-24
Recruiting
Eli Lilly and Company
Phase 3
800
Hamilton, Québec, Toronto, Vancouver
2025-12-22
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
450
Calgary, Hamilton, Québec, Vancouver
2025-12-12
Recruiting
Eli Lilly and Company
Phase 3
7,140
Brampton, Cambridge, Chicoutimi, Hamilton, Laval, Moncton, Montreal, Québec
2025-12-01
Recruiting
Eli Lilly and Company
Phase 2
252
Hamilton, London, Mississauga, Trois-Rivières
2025-11-10
Recruiting
Eli Lilly and Company
Phase 3
1,630
Calgary, Hamilton, Montreal, Sherbrooke, Surrey, Toronto
2025-10-22
Recruiting
Eli Lilly and Company
Phase 2
531
Ajax, Hamilton, Kelowna, Montreal, Québec, Richmond, Saint-Laurent, Toronto
2025-10-22
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Chicoutimi, Etobicoke, Hamilton, Joliette, Longueuil, Moncton, Montreal, North York
2025-09-02
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
NCT07114601Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm, Endometrial Neoplasms
Eli Lilly and Company
Phase 1
421
Hamilton, Montreal, Toronto
2025-08-06
Active, closed
Eli Lilly and Company
Phase 3
586
Brampton, Hamilton, Sarnia, Sydney, Toronto
2025-05-29
Recruiting
Eli Lilly and Company
Phase 2
200
Brampton, Chicoutimi, Hamilton, Longueuil, Moncton, Sarnia, Toronto, Waterloo
2025-03-28
Active, closed
Eli Lilly and Company
Phase 3
643
Brampton, Burlington, Courtice, Hamilton, Terrebonne, Thunder Bay, Toronto, Trois-Rivières
2025-03-05
Recruiting
Eli Lilly and Company
Phase 3
300
Hamilton, Sarnia
2024-06-03
Active, closed
[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
NCT06229366Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Oligometastatic Prostate Carcinoma, Hormone Sensitive Prostate Cancer
Eli Lilly and Company
Phase 1
142
Hamilton, Montreal, Québec, Saguenay, Toronto, Vancouver
2024-04-03
Active, closed
Eli Lilly and Company
Phase 3
17,300
Brampton, Chicoutimi, Hamilton, Joliette, London, Longueuil, Moncton, New Westminster
2024-03-05
Active, closed
Eli Lilly and Company
Phase 3
1,250
Calgary, Edmonton, Brampton, Hamilton, Sarnia, Toronto, Whitby, Montreal
2024-02-21
Active, closed
Eli Lilly and Company
Phase 3
160
Edmonton, Hamilton, Toronto, Chicoutimi
2023-10-16
Active, closed
Eli Lilly and Company
Phase 3
15,374
Brampton, Calgary, Chicoutimi, Courtice, Greater Sudbury, Halifax, Hamilton, Lévis
2022-10-11
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-canada/city/hamilton

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,567 studies in total at the last sync on 17 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies with a site in Hamilton that also match the filters currently applied.

How many clinical trials are recruiting in Hamilton?

12 of the 20 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hamilton), 20 studies
PhaseStudiesRecruitingShare
Phase 315875%
Phase 23315%
Phase 12110%

Most active sponsors

Lead sponsors with the most studies (Hamilton)
Lead sponsorStudiesRecruiting
Eli Lilly and Company2012
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.